NanoVibronix, Inc.
NAOV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.10 | 0.17 | -0.21 |
| FCF Yield | -73.11% | -75.40% | -14.65% | -2.66% |
| EV / EBITDA | -1.22 | -0.76 | -5.20 | -14.34 |
| Quality | ||||
| ROIC | -4.58% | -8.46% | -4.65% | -142.86% |
| Gross Margin | 26.18% | -7.09% | 36.00% | 63.74% |
| Cash Conversion Ratio | -3.28 | 1.01 | 0.54 | 0.38 |
| Growth | ||||
| Revenue 3-Year CAGR | 38.80% | 53.79% | 47.24% | 50.39% |
| Free Cash Flow Growth | 41.01% | -151.26% | -145.99% | 34.45% |
| Safety | ||||
| Net Debt / EBITDA | -4.42 | 0.56 | -1.38 | 0.46 |
| Interest Coverage | -42.40 | -27.61 | -29.40 | -40.29 |
| Efficiency | ||||
| Inventory Turnover | 0.24 | 0.24 | 0.32 | 0.07 |
| Cash Conversion Cycle | 327.08 | 350.33 | 365.35 | 1,252.83 |